NCT01194830 · Interventional trial
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study
Overall registry status Completed
Phase 3
Conditions Diabetes Mellitus, Type 2
Delaware Valley sites
- 1218.75.037 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
- 1218.75.082 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory